All PlansAdministrativeHigh impact
Voluntary nationwide recall: Exela Pharma (October)
UPMC Health Plan·Emergency Medicine, Critical Care, Anesthesiology·Pharmacy
We identified it
Jun 20, 2026
Summary
Exela Pharma has issued a voluntary nationwide recall of 8.4% Sodium Bicarbonate Injection (NDC: 51754-5001-04) due to silicone particles that could cause serious complications including stroke or death. Healthcare practices must immediately stop using recalled lots and verify inventory.
Action Required
Immediately: Clinical staff must check all inventory of 8.4% Sodium Bicarbonate Injection (NDC: 51754-5001-04) and quarantine any recalled lots. Pharmacy team should contact suppliers to verify lot numbers and arrange returns. Billing team should flag any recent administrations for potential adverse event documentation and reporting requirements.